UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New insight in the pathobiology of hepatitis B virus infection

Gut, 2012-05, Vol.61 (Suppl 1), p.i6-i17

2012

Volltextzugriff (PDF)

Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure

Hepatology international, 2008-06, Vol.2 (2), p.147-151

Locarnini, Stephen

2008

Volltextzugriff (PDF)

The evolution and clinical impact of hepatitis B virus genome diversity

Nature reviews. Gastroenterology & hepatology, 2020-10, Vol.17 (10), p.618-634

2020

Volltextzugriff (PDF)

The antiviral drug selected hepatitis B virus rtA181T/sW172 mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

Hepatology (Baltimore, Md.), 2008-07, Vol.48 (1), p.88-98

2008

Volltextzugriff (PDF)

Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities

Antiviral research, 2015-09, Vol.121, p.47-58

2015

Volltextzugriff (PDF)

The role of quantitative hepatitis B surface antigen revisited

Journal of hepatology, 2017-02, Vol.66 (2), p.398-411

2017

Volltextzugriff (PDF)

Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus

Journal of hepatology, 2014-09, Vol.61 (3), p.502-507

2014

Volltextzugriff (PDF)

RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg

Science translational medicine, 2017-09, Vol.9 (409)

2017

Volltextzugriff (PDF)

Present and future therapies of hepatitis B: From discovery to cure

Hepatology (Baltimore, Md.), 2015-12, Vol.62 (6), p.1893-1908

2015

Volltextzugriff (PDF)

Origins and Evolution of the Primate Hepatitis B Virus

Frontiers in microbiology, 2021-05, Vol.12, p.653684-653684

2021

Volltextzugriff (PDF)

Origins and Evolution of Hepatitis B Virus and Hepatitis D Virus

Cold Spring Harbor perspectives in medicine, 2016-01, Vol.6 (1), p.a021360-a021360

2016

Volltextzugriff (PDF)

The Hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway

Journal of hepatology, 2011-10, Vol.55 (4), p.762-769

2011

Volltextzugriff (PDF)

Hepatitis B virus infection

Nature reviews. Disease primers, 2018-06, Vol.4 (1), p.18035-18035, Article 18035

2018

Volltextzugriff (PDF)

Molecular genetics of HBV infection

Antiviral therapy, 2010-01, Vol.15 Suppl 3 (3_suppl), p.3-14

2010

Volltextzugriff (PDF)

RNA Interference Therapy With ARC‐520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection

Hepatology (Baltimore, Md.), 2020-07, Vol.72 (1), p.19-31

2020

Volltextzugriff (PDF)

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia

Journal of hepatology, 2010-04, Vol.52 (4), p.508-513

2010

Volltextzugriff (PDF)

The virological aspects of hepatitis B

Baillière's best practice & research. Clinical gastroenterology, 2017-06, Vol.31 (3), p.257-264

2017

Volltextzugriff (PDF)

Molecular genesis of drug-resistant and vaccine-escape HBV mutants

Antiviral therapy, 2010, Vol.15 (3 Pt B), p.451-461

2010

Volltextzugriff (PDF)

Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response

Immunology and cell biology, 2007-08, Vol.85 (6), p.435-445

2007

Volltextzugriff (PDF)

Perinatal transmission of hepatitis B virus: an Australian experience

Medical journal of Australia, 2009-05, Vol.190 (9), p.489-492

2009

Volltextzugriff (PDF)

In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes

Journal of virology, 2016-11, Vol.90 (22), p.10054-10064

2016

Volltextzugriff (PDF)

Selection of chronic hepatitis B therapy with high barrier to resistance

The Lancet infectious diseases, 2012-04, Vol.12 (4), p.341-353

2012

Volltextzugriff (PDF)

Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis

PloS one, 2014-07, Vol.9 (7), p.e90571

2014

Volltextzugriff (PDF)

1 – 25 von 494

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(416)
Mit Volltextzugriff
(433)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(349)
Life Sciences & Biomedicine
(344)
Humans
(254)
Gastroenterology & Hepatology
(177)
Virology
(150)
Infectious Diseases
(149)
Hepatitis B Virus - Genetics
(125)
Biological And Medical Sciences
(120)
Hepatitis B Virus
(115)
Medical Sciences
(107)
Hepatitis B
(93)
Antiviral Agents - Therapeutic Use
(86)
Female
(81)
Male
(80)
Adult
(68)
Viral Hepatitis
(68)
Hepatitis B, Chronic - Drug Therapy
(64)
Human Viral Diseases
(64)
Viral Diseases
(64)
Antiviral Agents
(61)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(52)
Hepatology
(43)
Antiviral Therapy
(23)
Gastroenterology
(21)
Journal Of Gastroenterology And Hepatology
(19)
Medical Journal Of Australia
(18)
Journal Of Medical Virology
(14)
Hepatology International
(12)
Journal Of Virology
(12)
Liver International
(12)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

New insight in the pathobiology of hepatitis B virus infection

Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure

The evolution and clinical impact of hepatitis B virus genome diversity

The antiviral drug selected hepatitis B virus rtA181T/sW172 mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities

The role of quantitative hepatitis B surface antigen revisited

Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus

Update of the statements on biology and clinical impact of occult hepatitis B virus infection

RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference

Present and future therapies of hepatitis B: From discovery to cure

Origins and Evolution of the Primate Hepatitis B Virus

Origins and Evolution of Hepatitis B Virus and Hepatitis D Virus

The Hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway

Hepatitis B virus infection

Molecular genetics of HBV infection

RNA Interference Therapy With ARC‐520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia

The virological aspects of hepatitis B

Molecular genesis of drug-resistant and vaccine-escape HBV mutants

Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response

Perinatal transmission of hepatitis B virus: an Australian experience

In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes

Selection of chronic hepatitis B therapy with high barrier to resistance

Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesis

Suchergebnisse filtern